What can pooled CRISPR screening and protein‑level readouts reveal that transcriptomics alone can't? Explore how single‑cell ...
A comprehensive review of solute carrier transporters argues that the 464-strong SLC protein family represents a largely ...
AI can rapidly generate new protein binders, but wet-lab validation remains a major bottleneck. Combining cell-free protein ...
A large real-world study published in Nature Medicine demonstrates that whole-genome sequencing can identify actionable ...
An experimental synthetic non-coding RNA drug has reversed signs of systemic sclerosis in patient-derived immune cells and ...
BioLife has been granted a US patent for its effervescent OralMatrix oral peptide delivery platform, with preclinical data ...
Whole-genome sequencing of parasites from Ugandan patients has uncovered a cluster of genetic variants linked to reduced ...
A £20 million high-security facility in Liverpool is set to accelerate drug and vaccine discovery by integrating artificial ...
What happens when the cellular machinery making therapeutic proteins slows down? New research in Nature shows why translation ...
UK genomics and drug discovery company OutSee has received £50,000 in Innovate UK funding to develop an agentic AI sub-system ...
Dr. Qiongsi Zhang serves as a Senior Product Scientist at Sino Biological, overseeing product development and optimization.
A new NIH-funded study suggests the GLP-1 receptor agonist semaglutide may slow biological ageing and extend lifespan in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results